what is in semaglutide that causes weight loss for Loss: How It Works, Comparisons, and More Weight-loss drug tied to lower

Another oral medication, called orforglipron, is also drawing attention

However, it can start anytime within the first 16 weeks (four months) of treatment

Fase-2-obesitasstudie (NEJM, 2023): bij volwassenen met obesitas/overgewicht leidde retatrutide tot gemiddeld ~17,5% gewichtsverlies op 24 weken en tot ~24% op 48 weken (secundaire uitkomst)

In MASH (metabolic dysfunction-associated steatohepatitis, formerly NASH), semaglutide 2.4 mg showed significant resolution of steatohepatitis in a proportion of patients

Why this is a major milestone First potential GLP-1 + amylin combination A complementary, biology-driven approach to appetite regulation and energy balance reinforcing obesity as a chronic disease, not a lifestyle failure